The current PE ratio of BAX can't be determined, as the TTM EPS of -$2.14 is negative. The last recorded PE ratio for Baxter International was 180.81 in September 2024.
The average historical PE ratio of Baxter International for the last ten years is 34.83. In the past ten years, BAX's PE ratio was at its highest in the Sep 2024 quarter at 180.81, when the stock price was $37.97 and the EPS was $0.21. The lowest value was in the Dec 2016 quarter, when it reached 4.88 with a price of $44.34 and an EPS of $9.09.
Maximum annual increase: 1,093.24% in 2017
Maximum annual decrease: -77.23% in 2016
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | N/A | N/A | $19.11 | -$1.87 |
| 2024 | N/A | N/A | $29.16 | -$1.27 |
| 2023 | 7.36 | N/A | $38.66 | $5.25 |
| 2022 | N/A | N/A | $50.97 | -$4.83 |
| 2021 | 33.53 | -9.33% | $85.84 | $2.56 |
| 2020 | 36.98 | -12.89% | $80.24 | $2.17 |
| 2019 | 42.45 | 87% | $83.62 | $1.97 |
| 2018 | 22.7 | -61.02% | $65.82 | $2.9 |
| 2017 | 58.23 | 1,093.24% | $64.64 | $1.11 |
| 2016 | 4.88 | -77.23% | $44.34 | $9.09 |
| 2015 | 21.43 | 34.78% | $38.15 | $1.78 |
| 2014 | 15.9 | -15.43% | $73.29 | $4.61 |
| 2013 | 18.8 | 18.99% | $69.55 | $3.7 |
| 2012 | 15.8 | 24.9% | $66.66 | $4.22 |
| 2011 | 12.65 | -39.76% | $49.48 | $3.91 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | N/A | N/A | $16.8 | -$2.14 |
| Dec 2025 | N/A | N/A | $19.11 | -$1.87 |
| Sep 2025 | N/A | N/A | $22.77 | -$0.66 |
| Jun 2025 | N/A | N/A | $30.28 | -$0.3 |
| Mar 2025 | N/A | N/A | $34.23 | -$1.1 |
| Dec 2024 | N/A | N/A | $29.16 | -$1.27 |
| Sep 2024 | 180.81 | 2,543.42% | $37.97 | $0.21 |
| Jun 2024 | 6.84 | -16.28% | $33.45 | $4.89 |
| Mar 2024 | 8.17 | 11.01% | $42.74 | $5.23 |
| Dec 2023 | 7.36 | 0% | $38.66 | $5.25 |
| Sep 2023 | 7.36 | N/A | $37.74 | $5.13 |
| Jun 2023 | N/A | N/A | $45.56 | -$5.65 |
| Mar 2023 | N/A | N/A | $40.56 | -$4.87 |
| Dec 2022 | N/A | N/A | $50.97 | -$4.83 |
| Sep 2022 | N/A | N/A | $53.86 | -$4.71 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BSX Boston Scientific Corp | 20.15 | $72.16B |
| MDT Medtronic plc | 22.69 | $104.85B |
| HALO Halozyme Therapeutics Inc | 24.17 | $8.48B |
| TMO Thermo Fisher Scientific Inc | 25.95 | $175.7B |
| CAH Cardinal Health Inc | 31.31 | $48.18B |
| SYK Stryker Corp | 34.97 | $117.18B |
| BDX Becton Dickinson & Co | 38.27 | $41.65B |
| ICUI Icu Medical Inc | 73.05 | $3.41B |
| ACH Accendra Health Inc. | N/A | $206.78M |
| BAX Baxter International Inc | N/A | $10.01B |
The current price to earnings ratio of BAX can't be calculated, as its EPS of -$2.14 is negative.
As an average over the last 3 years, BAX stock has a PE ratio of 42.11.
As an average over the last 5 years, BAX stock has a PE ratio of 38.21.
The highest quarterly PE ratio in the last ten years has been 180.81 and it was in the Sep 2024 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.